Danish Anaesthesia Allergy Centre, Allergy Clinic KAA-816, Department of Dermato-Allergology, Copenhagen University Hospital, Gentofte Hospital, and Department of Anaesthesia, Centre for Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Denmark.
Anesthesiology. 2011 Jul;115(1):111-6. doi: 10.1097/ALN.0b013e318218119d.
Literature on the use of epinephrine in the treatment of anaphylaxis during anesthesia is very limited. The objective of this study was to investigate how often epinephrine is used in the treatment of suspected anaphylaxis during anesthesia in Denmark and whether timing of treatment is important.
A retrospective study of 270 patients investigated at the Danish Anaesthesia Allergy Centre after referral due to suspected anaphylaxis during anesthesia was performed. Reactions had been graded by severity: C1, mild reactions; C2, moderate reactions; C3, anaphylactic shock with circulatory instability; C4, cardiac arrest. Use of epinephrine, dosage, route of administration, and time between onset of circulatory instability and epinephrine administration were noted.
A total of 122 (45.2%) of referred patients had C3 or C4 reactions; of those, 101 (82.8%) received epinephrine. Route of administration was intravenous in 95 (94%) patients. Median time from onset of reported hypotension to treatment with epinephrine was 10 min (range, 1-70 min). Defining epinephrine treatment less than or equal to 10 min after onset of hypotension as early, and more than 10 min as late, infusion was needed in 12 of 60 patients (20%) treated early versus 12 of 35 patients (34%) treated late (odds ratio, 2.09) (95% confidence interval, 0.81-5.35).
Anaphylaxis may be difficult to diagnose during anesthesia, and treatment with epinephrine can be delayed as a consequence. Anaphylaxis should be considered and treated in patients with circulatory instability during anesthesia of no apparent cause who do not respond to the usual treatments.
关于麻醉期间使用肾上腺素治疗过敏反应的文献非常有限。本研究旨在调查在丹麦麻醉期间疑似过敏反应时使用肾上腺素的频率,以及治疗时机是否重要。
对因疑似麻醉期间过敏反应而转诊至丹麦麻醉过敏中心的 270 名患者进行了回顾性研究。反应严重程度分级为:C1,轻度反应;C2,中度反应;C3,过敏性休克伴循环不稳定;C4,心脏骤停。记录肾上腺素的使用、剂量、给药途径以及循环不稳定与肾上腺素给药之间的时间间隔。
共有 122 名(45.2%)转诊患者发生 C3 或 C4 反应;其中 101 名(82.8%)接受了肾上腺素治疗。95 名(94%)患者采用静脉途径给药。从报告低血压开始到给予肾上腺素治疗的中位数时间为 10 分钟(范围,1-70 分钟)。将低血压发作后≤10 分钟定义为早期,>10 分钟定义为晚期,在早期治疗的 60 名患者中有 12 名(20%)需要输注,而在晚期治疗的 35 名患者中有 12 名(34%)需要输注(比值比,2.09)(95%置信区间,0.81-5.35)。
麻醉期间过敏反应可能难以诊断,并且治疗可能会延迟。在没有明显原因的循环不稳定且对常规治疗无反应的麻醉患者中,应考虑并治疗过敏反应。